Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Treasury Shares (2017 - 2018)

Marker Therapeutics (MRKR) has disclosed Treasury Shares for 2 consecutive years, with $7561.0 as the latest value for Q4 2018.

  • On a quarterly basis, Treasury Shares fell 92.26% to $7561.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $7561.0, a 92.26% decrease, with the full-year FY2018 number at $7561.0, down 92.26% from a year prior.
  • Treasury Shares was $7561.0 for Q4 2018 at Marker Therapeutics, down from $97639.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $97639.0 in Q3 2017 to a low of $7561.0 in Q4 2018.